- Who can participate: Adults aged 18 to 65 with a diagnosis of type 2 diabetes who are not currently on insulin therapy may be eligible to participate.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. They will attend regular clinic visits for monitoring and assessment of their health and treatment response.